Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Free Cash Flow: 2015-2025

Historic Free Cash Flow for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -$66.8 million.

  • AC Immune's Free Cash Flow fell 314.24% to -$66.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.5 million, marking a year-over-year decrease of 320.25%. This contributed to the annual value of $74.5 million for FY2024, which is 207.23% up from last year.
  • Per AC Immune's latest filing, its Free Cash Flow stood at -$66.8 million for Q3 2025, which was down 249.44% from -$19.1 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Free Cash Flow peaked at $80.8 million during Q2 2024, and registered a low of -$66.8 million during Q3 2025.
  • Over the past 3 years, AC Immune's median Free Cash Flow value was -$16.1 million (recorded in 2024), while the average stood at -$9.4 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 617.89% in 2024, then slumped by 1,548.68% in 2025.
  • AC Immune's Free Cash Flow (Quarterly) stood at -$24.3 million in 2021, then increased by 15.12% to -$20.6 million in 2022, then rose by 2.55% to -$20.1 million in 2023, then surged by 127.71% to $5.6 million in 2024, then slumped by 314.24% to -$66.8 million in 2025.
  • Its Free Cash Flow stands at -$66.8 million for Q3 2025, versus -$19.1 million for Q2 2025 and -$21.1 million for Q1 2025.